SEC Form 4 · accession 0001349929-16-000128
CANCER GENETICS, INC · CGIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Pappajohn
Director · 10% Owner
Period of report
Nov 14, 2016
Accepted (ET)
Nov 16, 2016 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001349929
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Nov 14, 2016 | P | 31,100 | $1.4807 | A | 2,320,709 | D |
Table II — derivative securities
No Table II lines on this filing.